BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6247214)

  • 1. The effects of opiate agonists on growth hormone and prolactin release in rats.
    Shaar CJ; Clemens JA
    Fed Proc; 1980 Jun; 39(8):2539-43. PubMed ID: 6247214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
    Pechnick R; George R; Poland RE
    J Pharmacol Exp Ther; 1985 Jan; 232(1):170-7. PubMed ID: 2981314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of enkephalin analogues Tyr-D-Ala-Gly-Phe-Cys(Et) and Tyr-D-Ala-Gly-Phe-Cys(Bu) on prolactin and growth hormone release in rats.
    Nedvídková J; Kasafírek E; Dlabac A
    Endocrinol Exp; 1988 Dec; 22(4):255-9. PubMed ID: 3243206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholaminergic regulation of opiate-stimulated growth hormone secretion in the developing rat.
    Bero LA; Kuhn CM
    J Pharmacol Exp Ther; 1986 Apr; 237(1):137-42. PubMed ID: 3007734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
    Bero LA; Kuhn CM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of dopamine release in rat striatal slices by delta opiate agonists.
    Lubetzki C; Chesselet MF; Glowinski J
    J Pharmacol Exp Ther; 1982 Aug; 222(2):435-40. PubMed ID: 6284911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of multiple opiate receptors through neuroendocrine responses. I. Effects of agonists.
    Pechnick R; George R; Poland RE
    J Pharmacol Exp Ther; 1985 Jan; 232(1):163-9. PubMed ID: 2981313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin.
    Rivier C; Vale W; Ling N; Brown M; Guillemin R
    Endocrinology; 1977 Jan; 100(1):238-41. PubMed ID: 187406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of methionine-enkephalin and morphine in the stimulation of gastric acid secretion in the dog.
    Konturek SJ; Tasler J; Cieszkowski M; Mikoś E; Coy DH; Schally AV
    Gastroenterology; 1980 Feb; 78(2):294-300. PubMed ID: 6243110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
    Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the 2-deoxy-D-glucose-induced vagal stimulation of gastric secretion and gastrin release in dogs using methionine-enkephalin, morphine and naloxone.
    Anderson W; Molina E; Rentz J; Hirschowitz BI
    J Pharmacol Exp Ther; 1982 Sep; 222(3):617-22. PubMed ID: 6809930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the interaction of endorphins, substance P. and endogenous somatostatin in growth hormone and prolactin release in rats.
    Chihara K; Arimura A; Coy DH; Schally AV
    Endocrinology; 1978 Jan; 102(1):281-90. PubMed ID: 217585
    [No Abstract]   [Full Text] [Related]  

  • 15. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
    Cahill CM; White TD; Sawynok J
    J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of neurotensin, substance P and morphine sulfate on the secretion of prolactin and growth hormone in the rat.
    Rivier C; Brown M; Vale W
    Endocrinology; 1977 Mar; 100(3):751-4. PubMed ID: 95701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
    Cicero TJ; Nock B; O'Connor L
    J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse.
    Porreca F; Burks TF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):22-7. PubMed ID: 6312019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY; Bergsbaken C
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues.
    Capasso A; Di Giannuario A; Loizzo A; Pieretti S; Sagratella S; Sorrentino L
    J Pharmacol Exp Ther; 1996 Feb; 276(2):743-51. PubMed ID: 8632345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.